How long does it take for Skyrizi to work?
- Skyrizi can start to show an improvement in psoriasis and psoriatic arthritis in 4 weeks for some patients, with an increasing number of patients having a reduction in symptoms over 16 weeks and beyond.
- Using Skyrizi for psoriasis 6% of patients had a 90% reduction in their psoriasis score at four weeks. By week sixteen, 76% of patients had a 90% reduction in their psoriasis score.
- When using Skyrizi for psoriatic arthritis at 4 weeks 25.7% of Skyrizi patients had psoriatic arthritis symptoms reduced by 20%, and by 24 weeks this had increased to 57.3% of Skyrizi patients.
- When using Skyrizi for Crohn's disease, patients start to have a clinical response within 4 weeks and by 12 weeks 23% more Skyrizi patients had a clinical response compared to placebo.
Skyrizi (risankizumab-rzaa) is an injection given under the skin (subcutaneous injection) to treat patients who have moderate or severe plaque psoriasis (raised, silvery flaking of the skin) and for active psoriatic arthritis (PsA) which is a systemic inflammatory disease which affects the skin and joints.
How long does it take for Skyrizi to work for Psoriasis?
First of all, how do you measure improvement in psoriasis?
- To measure how good or bad your psoriasis is, a score is used called the PASI (Psoriasis Area and Severity Index).
- It scores your psoriasis on redness, thickness, amount of scaling and how much of the body is affected.
- If your psoriasis score has a 90% reduction it is called PASI 90. If you had a 100% reduction in your PASI score would be a PASI 100.
Data from the LIMMitless phase 3 study looked at the percentage of psoriasis patients who achieved 90% improvement in their PASI score (PASI 90) and results showed that Skryrizi starts working:
- Within the first 4 weeks in which 6% Skyrizi patients achieved PASI90.
- By 8 weeks 44% of patients achieved PASI90.
- By 16 weeks 76% of patients achieved PASI90, compared to 5% for the placebo group.
- By 52 weeks 86% of patients achieved PASI90.
How long does it take for Skyrizi to work for psoriatic arthritis?
Improvements in psoriatic arthritis are measured by American College of Rhematology (ACR) Criteria which is a combined score of the number of tender joints, the number of swollen joints and also includes three of the following five criteria:
- patient assessment on disease severity,
- physician assessment on disease severity,
- level of functional ability,
- level of pain
- erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP).
An ACR20 is when there is a 20% improvement in tender or swollen joint counts, as well as a 20% improvement in at least three of the other five above criteria.
The phase 3 KEEPsAKE 1 trial showed how long it took for Skyrizi to improve psoriatic arthritis. The results of the study showed the number of Skyrizi patients who had a 20% improvement (ACR20) in their psoriatic arthritis, compared to placebo patients.
The percentage of patients that achieved a 20% improvement in psoriatic arthritis:
- At four weeks Skyrizi 25.7%, compared to placebo 13.7%. (Difference 25.7% - 13.7% = 12%)
- At 8 weeks Skyrizi 43.9%, compared to placebo 28.8%. (Difference 43.9% - 28.8% = 15.1%)
- At 16 weeks Skyrizi 56.3%, compared to placebo 33.4%. (Difference 56.3% - 33.4% = 22.9%)
- At 24 weeks Skyrizi 57.3%, compared to placebo 33.5%. (Difference 57.3% - 33.5% = 23.8%)
Related questions
- What does psoriasis look like?
- How do you get psoriasis and is it contagious?
- How does Tremfya work to treat plaque and psoriatic arthritis?
How long does it take for Skyrizi to work for Crohn’s disease?
For Crohn’s disease Skyrizi starts to have a significant clinical response in as early as 4 weeks. A clinical response for Crohn’s disease is defined as a 100-point reduction in Crohn's Disease Activity Index [CDAI] ).
After 12 weeks 23% more Skyrizi patients clinical response to Skyrizi compared to placebo patients (Skyrizi 60% - placebo 37%= 23%)
Bottom Line:
- Skyrizi injection when used for psoriasis starts to work within four weeks for some patients, with 6% of patients seeing a 90% reduction in their PASI score.
- Skyrizi patients continued to see an improvement in plaque psoriasis symptoms, so that by week 52, 86% have a PASI 90 and by 59% achieve a PASI 100.
- When using Skyrizi for psoriatic arthritis, improvement starts within four weeks with 25.7% of Skyrizi patients reaching a 20% improvement in ACR (American College of Rhematology) Criteria.
- Skyrizi psoriatic arthritis patients had further improvement by week 24 with 57.3% of the Skyrizi patients reaching ACR20.
- For Crohn's disease after 12 weeks 23% more Skyrizi patients clinical response to Skyrizi compared to placebo patients (Skyrizi 60% - placebo 37%= 23%)
References
- Risankizumab for psoriasis [Accessed February 3, 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186275/
- PASI score DermNet NZ [Accessed February 3, 2022] https://dermnetnz.org/topics/pasi-score
- Skyrizi Professional Medication information [Accessed August 11, 2022] https://www.drugs.com/pro/skyrizi-injection.html
- American College of Rheumatology 20/50/70 criteria (ACR20/50/70) [Accessed February 9, 2022] https://eprovide.mapi-trust.org/instruments/american-college-of-rheumatology-20-50-70-criteria
- Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial [Accessed February 3, 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762015/
- Durable efficacy in psoriasis achieved by SKYRIZI patients through to 4.5 years*2 [Accessed February 3, 2022] https://www.abbviepro.com/gb/en/immunology/dermatology/products/skyrizi/efficacy.html
- Skyrizi (risankizumab-rzaa) Receives FDA Approval as the First and Only Specific Interleukin-23 (IL-23) to Treat Moderately to Severely Active Crohn's Disease in Adults [Accessed August 11, 2022] https://www.drugs.com/newdrugs/skyrizi-risankizumab-rzaa-receives-fda-approval-first-only-specific-interleukin-23-il-23-moderately-5853.html
Read next
How does Ilumya work to treat psoriasis?
Ilumya works by binding selectively to interleukin-23 (IL-23) which is a naturally occurring cytokine. IL-23 plays a key role in promoting inflammation and regulating other cytokines (such as IL-17) and inflammatory substances, such as TNF-α3-7. By blocking the effects of IL-23, Ilumya helps control the release of IL-17 and TNF-α, which reduces inflammation associated with psoriasis. It also decreases how many inflammatory cells are present within psoriatic lesions, helps prevent plaque formation, and resolves tissue damage. Continue reading
Prednisone: What are 12 Things You Should Know?
Prednisone first came onto the market over sixty years ago and is still going strong. But did you know that this common drug used for a variety of different conditions also has some pretty serious side effects as well? Continue reading
Where should you not use triamcinolone acetonide cream?
You should not use topical corticosteroids like triamcinolone acetonide cream on your face, groin, or axillae (underarm, armpit) unless directed by your doctor. Using triamcinolone in these areas may lead to unwanted side effects like acne, prominent blood vessels, skin thinning (atrophy), changes in skin color or unwanted hair growth. Continue reading
Related medical questions
- What are the new drugs for plaque psoriasis?
- Why should I take folic acid with methotrexate?
- Is triamcinolone acetonide an antifungal cream?
- How do you use clobetasol propionate on your scalp?
- Clobetasol vs. triamcinolone - how do they compare?
- What is a substitute for fluocinonide cream?
- How long does methotrexate stay in your system?
- Halobetasol vs. clobetasol - How do they compare?
- Does taking vitamin D help with psoriasis?
- What causes Plaque Psoriasis?
- Sotyktu vs Otezla: How do they compare?
- Can clobetasol be used for toenail fungus?
- How does Taltz compare to Cosentyx for psoriatic arthritis?
- Is fluocinonide an antifungal cream?
- How long does it take for Otezla to work?
- How long does clobetasol stay in your system?
- How long should you use fluocinonide for?
- Does Feverfew interact with any drugs?
- How do you inject Humira?
- What are 6 key Taltz side effects to watch out for?
- Cosentyx vs Humira: How do they compare?
- What's the dosing schedule for Skyrizi?
- What happens if Cosentyx is not refrigerated?
- What is the mechanism of action of infliximab?
- Does Cosentyx cause weight gain or loss?
- What is fluocinonide cream good for?
- Who is the actress in the Stelara commercial?
- What does Otezla do to the body?
- Can Enstilar be used on the scalp?
- Does Skyrizi cause cancer?
Drug information
- Skyrizi Information for Consumers
- Skyrizi prescribing info & package insert (for Health Professionals)
- Side Effects of Skyrizi (detailed)
Related support groups
- Psoriasis (104 questions, 308 members)
- Skyrizi (17 questions, 7 members)
- Psoriatic Arthritis (87 questions, 278 members)